Analyst firms · Piper Sandler · MASI
Piper Sandler MASI price target and rating history
Masimo Corporation (MASI) · Health Care
Piper Sandler rates Masimo Corporation (MASI) Overweight with a $160 price target, as of its latest action on Jun 3, 2024. It has published 3 rating actions on MASI since November 2021, including 1 upgrade and 1 downgrade.
- Current rating
- Overweight
- Price target
- $160
- Median target, all firms
- Too few
- Actions on MASI
- 3
Piper Sandler price target on MASI
Every Piper Sandler rating on MASI
- Jun 3, 2024
- Feb 16, 2022
- Nov 15, 2021
How other firms rate MASI
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Raymond James | Mkt Perform | Mar 27, 2026 | |
| BofA Securities | Neutral | Nov 17, 2025 |
Questions about Piper Sandler and MASI
- What is Piper Sandler's price target for MASI?
- Piper Sandler's latest stated price target for Masimo Corporation (MASI) is $160, from its action on Jun 3, 2024.
- What is Piper Sandler's rating on MASI?
- Piper Sandler rates MASI Overweight, a bullish rating, as of Jun 3, 2024.
- When did Piper Sandler last change its view on MASI?
- On Jun 3, 2024, Piper Sandler upgrades to Overweight from Neutral, price target $126 to $160.
More MASI rating histories
All Piper Sandler ratingsMASI news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.